Analyze Diet
Journal of veterinary pharmacology and therapeutics2018; 41(6); 843-847; doi: 10.1111/jvp.12703

Evaluation of pharmacokinetic properties of vitacoxib in fasted and fed horses.

Abstract: The pharmacokinetic properties of vitacoxib have not been established completely; current dosage recommendations are based on clinical experiences. The primary objective of this study was to describe plasma concentrations and characterize the pharmacokinetics of vitacoxib formulation following oral administrations in horses. Also, the effect of the state of stomach contents on the absorption of vitacoxib was investigated in fed/fasted horses. Blood samples were collected prior to and at various times up to 72 hr post-administration. Drug concentrations were measured using ultra high-performance liquid chromatography-tandem mass spectrometry. Pharmacokinetic parameters were calculated using Non-Compartmental Analysis Model 200 in WinNonlin™ software. No complications resulting from the vitacoxib administration were noted. All procedures were tolerated well by the horses throughout the study. C was 17.5 ± 9.36 ng/ml (fasted) and 9.47 ± 3.53 ng/ml (fed) following oral administrations. AUC was 173.7 ± 137.9 ng hr/ml (fasted) and 113.2 ± 70.8 ng h/ml (fed). No significant differences in pharmacokinetic parameters were noted and the results from the pharmacokinetic analysis were similar between the studies, regardless of precision of dosage and fasted and fed conditions. The study extends previous studies describing the pharmacokinetics of vitacoxib following p.o. administration to the horses. Further studies investigating the pharmacokinetics/pharmacodynamics of vitacoxib are necessary to establish adequate therapeutic protocols (optimal dosage and frequency of administration) in horses.
Publication Date: 2018-08-03 PubMed ID: 30076623DOI: 10.1111/jvp.12703Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Clinical Trial
  • Veterinary
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research evaluates the absorption and effect of vitacoxib (a drug) in horses, when administered orally, and how this varies when the horses are fed or fasting. The results indicate no significant difference in the drug’s behavior related to the horse’s fed or fasting state.

Overview of the Study

  • The study aims to understand the pharmacokinetic properties of vitacoxib, a drug administered to horses. Pharmacokinetic properties refer to how the drug is absorbed, distributed, metabolized, and excreted by the body.
  • Current dosage recommendations for vitacoxib are based on clinical experiences, so the researchers sought to take a more objective scientific approach to determining the right dosage.
  • One of the aspects they focused on was the effect of a horse’s feeding status (fasted or fed) on the absorption of vitacoxib.

Methodology

  • The horses were given the drug orally, and their blood samples were collected at various times up to 72 hours after administration.
  • The drug concentrations in the samples were then measured using ultra-high-performance liquid chromatography-tandem mass spectrometry, a process that allows researchers to analyze mixtures very accurately.
  • The researchers then used the Non-Compartmental Analysis Model 200 in WinNonlin™ software to calculate the pharmacokinetic parameters. This analysis calculates parameters like the maximum concentration of the drug (Cmax), the time to reach that concentration (Tmax), and the area under the curve (AUC), which represents the body’s exposure to drug over time.

Results and implications

  • No complications resulted from the vitacoxib administration, and the horses tolerated the procedure well.
  • Regardless of whether the horses were fed or fasted, vitacoxib’s pharmacokinetic parameters did not show significant differences, meaning the drug’s absorption and effect remained similar.
  • The researchers concluded that further studies are needed to establish adequate therapeutic protocols, such as optimal dosage and frequency of vitacoxib administration for horses.

Cite This Article

APA
Wang J, Xue J, Kong J, Li J, Zhang S, Cao X. (2018). Evaluation of pharmacokinetic properties of vitacoxib in fasted and fed horses. J Vet Pharmacol Ther, 41(6), 843-847. https://doi.org/10.1111/jvp.12703

Publication

ISSN: 1365-2885
NlmUniqueID: 7910920
Country: England
Language: English
Volume: 41
Issue: 6
Pages: 843-847

Researcher Affiliations

Wang, Jianzhong
  • Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing, China.
  • Laboratory of Quality & Safety Risk Assessment for Animal Products on Chemical Hazards (Beijing), Ministry of Agriculture and Rural affairs, Beijing, China.
Xue, Jiao
  • Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing, China.
  • Laboratory of Quality & Safety Risk Assessment for Animal Products on Chemical Hazards (Beijing), Ministry of Agriculture and Rural affairs, Beijing, China.
Kong, Jingyuan
  • Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing, China.
  • Laboratory of Quality & Safety Risk Assessment for Animal Products on Chemical Hazards (Beijing), Ministry of Agriculture and Rural affairs, Beijing, China.
Li, Jing
  • Beijing Orbiepharm Co. Ltd., Beijing, China.
Zhang, Suxia
  • Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing, China.
  • Laboratory of Quality & Safety Risk Assessment for Animal Products on Chemical Hazards (Beijing), Ministry of Agriculture and Rural affairs, Beijing, China.
Cao, Xingyuan
  • Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing, China.
  • Laboratory of Quality & Safety Risk Assessment for Animal Products on Chemical Hazards (Beijing), Ministry of Agriculture and Rural affairs, Beijing, China.
  • Key Laboratory of Detection for Veterinary Drug Residues and Illegal Additives, Ministry of Agriculture and Rural affairs, Beijing, China.

MeSH Terms

  • Administration, Oral
  • Animals
  • Area Under Curve
  • Cyclooxygenase 2 Inhibitors / administration & dosage
  • Cyclooxygenase 2 Inhibitors / chemistry
  • Cyclooxygenase 2 Inhibitors / pharmacokinetics
  • Female
  • Food Deprivation
  • Half-Life
  • Horses / blood
  • Imidazoles / administration & dosage
  • Imidazoles / chemistry
  • Imidazoles / pharmacokinetics
  • Male
  • Molecular Structure
  • Random Allocation
  • Sulfones / administration & dosage
  • Sulfones / chemistry
  • Sulfones / pharmacokinetics

Grant Funding

  • 31672599 / National Natural Science Foundation
  • 2016YFD0501309-1 / Projects in the National Science & Technology Pillar Program during the Thirteenth Five-Year Plan Period
  • GJFP2018700701 / Quality & Safety Risk Assessment for Animal Products on Chemical Hazards Foundation of China

Citations

This article has been cited 3 times.
  1. Wang J, Kong J, Yang Y, Liu Y, Qiu J, Gong X, Zhang L, Li J, Sun F, Cao X. Pharmacokinetics, Tissue Distribution, Metabolism and Excretion of a Novel COX-2 Inhibitor, Vitacoxib, in Rats. Front Vet Sci 2022;9:884357.
    doi: 10.3389/fvets.2022.884357pubmed: 35464368google scholar: lookup
  2. Wang J, Schneider BK, Xiao H, Qiu J, Gong X, Seo YJ, Li J, Mochel JP, Cao X. Non-Linear Mixed-Effects Pharmacokinetic Modeling of the Novel COX-2 Selective Inhibitor Vitacoxib in Cats. Front Vet Sci 2020;7:554033.
    doi: 10.3389/fvets.2020.554033pubmed: 33102567google scholar: lookup
  3. Wu F, Zhou Y, Li L, Shen X, Chen G, Wang X, Liang X, Tan M, Huang Z. Computational Approaches in Preclinical Studies on Drug Discovery and Development. Front Chem 2020;8:726.
    doi: 10.3389/fchem.2020.00726pubmed: 33062633google scholar: lookup